Donald J Hayden Jr is Director of Theseus Pharmaceuticals, Inc.. Currently has a direct ownership of 0 shares of THRX, which is worth approximately $0. The most recent transaction as insider was on Feb 14, 2024, when has been sold 10,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
100.0% 12M change
Total Value Held $0

DONALD J HAYDEN Jr Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 14 2024
SELL
Disposition due to a tender of shares in a change of control transaction
-
10,000 Reduced 100.0%
0 Common Stock
Dec 30 2022
BUY
Open market or private purchase
$49,500 $5.0 p/Share
9,900 Added 49.75%
10,000 Common Stock
Dec 29 2022
BUY
Open market or private purchase
$500 $5.0 p/Share
100 Added 50.0%
100 Common Stock
DJH

Donald J Hayden Jr

Director
Cambridge, MA

Track Institutional and Insider Activities on THRX

Follow Theseus Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells THRX shares.

Notify only if

Insider Trading

Get notified when an Theseus Pharmaceuticals, Inc. insider buys or sells THRX shares.

Notify only if

News

Receive news related to Theseus Pharmaceuticals, Inc.

Track Activities on THRX